D
Context Therapeutics Inc. CNTX
$0.8595 -$0.0134-1.54% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -84.24% -29.60% -11.52% -45.30% 0.87%
Total Depreciation and Amortization 27.52% 7.83% -9.92% -16.54% -14.84%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 1,644.44% 1,376.68% 1,284.85% 1,273.45% -21.99%
Change in Net Operating Assets 167.77% -683.30% -295.76% -228.00% -392.94%
Cash from Operations 3.81% 22.64% 30.84% 4.92% -6.49%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -84.67% -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -84.73% -- -- -- --
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -123.59% 502.76% 479.99% 455.63% 529.61%